Dr Paul Shaw
Leads Velindre’s lung trial portfolio and the drug radiotherapy workstream within the Early Phase Trials Unit at Velindre.
Expert Type: Expert Clinicians and Researchers
Professor Richard Clarkson
Founder of Clarkson lab at Cardiff University which has identified two genes that affect the spread of cancer.
Professor Andrew Westwell
Discovery and pre-clinical development of new anticancer drugs targeting advanced and metastatic disease and Independent Board Member of Velindre University NHS Trust.
Dr Philip Savage
Clinical Academic in Cancer Immuno-oncology at Cardiff University.
Dr Keith Wilson
Consultant Haematologist and Clinical Lead for blood and bone marrow transplantation at Cardiff and Vale University Health Board.
Dr James Powell
Specialising in neuro-oncology, leading on brain tumour collaborations with CUBRIC and Clinical Lead for ARC Academy.
Dr Ricky Frazer
By creo
Specialising in renal cancer, skin cancer and immunotherapy and Clinical Lead for the Acute Oncology Assessment Unit and the Immunotherapy Toxicity Management Service at Velindre Cancer Centre.
Professor Robert Jones
By creo
Internationally recognised Chief Investigator specialising in colorectal cancer and Solid Tumour Lead for the Cardiff Experimental Cancer Medicine Centre.
Dr Ceri Bygrave
By creo
Director for Haematology Research and Development at University Hospital of Wales, specialising in myeloma clinical trials.
Professor Steven Knapper
By creo
Haematological Cancer Lead at University Hospital of Wales, researching the development of targeted therapeutic agents in myeloid malignancies; both in pre-clinical laboratory studies and clinical research.